Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2021

Feb 12, 2021

32870_dirs_2021-02-11_86b20f78-a96d-46f2-8975-0db1749b950a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2021-02-09

Reporting Person: Kramer Robert (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-09 Common Stock A 2958 Acquired 142168 Direct
2021-02-09 Common Stock F 3870 $123.45 Disposed 138298 Direct
2021-02-09 Common Stock A 323 Acquired 138621 Direct
2021-02-09 Common Stock F 423 $123.45 Disposed 138198 Direct

Footnotes

F1: Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 8,875 shares of common stock, which is in excess of the 5,917 shares previously reported on March 1, 2018.

F2: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs.

F3: Consists of PSUs previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year,as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 969 shares of common stock, which is in excess of the 646 shares previously reported on May 10, 2018.